Mbey P, Diangienda P, Mukuku O, Arung W, Banza C, Mafuta A
Cancer Rep (Hoboken). 2025; 8(3):e70166.
PMID: 40067073
PMC: 11894822.
DOI: 10.1002/cnr2.70166.
Li J, Yang X, Yin C, Li S, Xu Y, Liu B
Discov Oncol. 2025; 16(1):246.
PMID: 40014167
PMC: 11867994.
DOI: 10.1007/s12672-025-01992-8.
Imam M, Ji J, Zhang Z, Yan S
Front Pharmacol. 2025; 15:1493188.
PMID: 39867656
PMC: 11757020.
DOI: 10.3389/fphar.2024.1493188.
Cong Y, Li N, Zhang Z, Shang Y, Zhao H
J Transl Med. 2025; 23(1):104.
PMID: 39844182
PMC: 11752808.
DOI: 10.1186/s12967-025-06121-1.
Huang Y, Luo G, Sheng X, Li J
Sci Rep. 2025; 15(1):2210.
PMID: 39825108
PMC: 11742449.
DOI: 10.1038/s41598-025-86756-8.
Zinc, copper, copper-to-zinc ratio, and other biometals in blood serum and tumor tissue of patients with colorectal cancer.
Skalny A, Kushlinskii N, Korobeinikova T, Alferov A, Kuzmin Y, Kochkina S
Biometals. 2025; .
PMID: 39820949
DOI: 10.1007/s10534-024-00660-8.
Construction of a cuproptosis-tricarboxylic acid cycle-associated lncRNA model to predict the prognosis of non-small cell lung cancer.
Li X, Zhao Y, Wei S, Dai Y, Yi C
Transl Cancer Res. 2025; 13(12):6807-6824.
PMID: 39816567
PMC: 11729758.
DOI: 10.21037/tcr-24-660.
A histochemical approach to activity-based copper sensing reveals cuproplasia-dependent vulnerabilities in cancer.
Messina M, Torrente L, Pezacki A, Humpel H, Li E, Miller S
Proc Natl Acad Sci U S A. 2025; 122(3):e2412816122.
PMID: 39813247
PMC: 11761388.
DOI: 10.1073/pnas.2412816122.
Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells.
Jasmer K, Shanbhag V, Munoz Forti K, Woods L, Gudekar N, Weisman G
Clin Exp Metastasis. 2024; 42(1):7.
PMID: 39714512
DOI: 10.1007/s10585-024-10325-y.
Cuproptosis: a promising new target for breast cancer therapy.
Jiang Q, Tong F, Xu Y, Liu C, Xu Q
Cancer Cell Int. 2024; 24(1):414.
PMID: 39702350
PMC: 11661134.
DOI: 10.1186/s12935-024-03572-2.
Copper metabolism-related lncRNAs predict prognosis and immune landscape in liver cancer patients.
Luo R, Huang S, Shi X, Xu H, Peng J, Lei W
Transl Cancer Res. 2024; 13(11):5784-5800.
PMID: 39697711
PMC: 11651766.
DOI: 10.21037/tcr-24-611.
Novel cuprotosis-related gene signature: a prognostic indicator and regulator of the glioma immune microenvironment.
Gao D, Zhou L, Bao Y, Shi W, Li L, Gao L
Transl Cancer Res. 2024; 13(11):6282-6297.
PMID: 39697708
PMC: 11651775.
DOI: 10.21037/tcr-24-1860.
Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer.
Liu X, Zhang W, Wei S, Liang X, Luo B
Front Pharmacol. 2024; 15:1451067.
PMID: 39691393
PMC: 11649426.
DOI: 10.3389/fphar.2024.1451067.
Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy.
Bhatnagar K, Jha K, Dalal N, Patki N, Gupta G, Kumar A
Front Immunol. 2024; 15:1442788.
PMID: 39676876
PMC: 11638209.
DOI: 10.3389/fimmu.2024.1442788.
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.
Rouaen J, Salerno A, Shai-Hee T, Murray J, Castrogiovanni G, McHenry C
Nat Commun. 2024; 15(1):10462.
PMID: 39668192
PMC: 11638255.
DOI: 10.1038/s41467-024-54689-x.
Bacterial Metallostasis: Metal Sensing, Metalloproteome Remodeling, and Metal Trafficking.
Capdevila D, Rondon J, Edmonds K, Rocchio J, Villarruel Dujovne M, Giedroc D
Chem Rev. 2024; 124(24):13574-13659.
PMID: 39658019
PMC: 11672702.
DOI: 10.1021/acs.chemrev.4c00264.
Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review).
Wu P, Chen J, Li H, Lu H, Li Y, Zhang J
Oncol Rep. 2024; 53(2).
PMID: 39635847
PMC: 11638741.
DOI: 10.3892/or.2024.8851.
Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer.
Zhou M, Tang J, Huang G, Hong L
Biomedicines. 2024; 12(11).
PMID: 39595204
PMC: 11592286.
DOI: 10.3390/biomedicines12112640.
An Activity-Based Sensing Approach to Multiplex Mapping of Labile Copper Pools by Stimulated Raman Scattering.
Jiang Y, El Khoury E, Pezacki A, Qian N, Oi M, Torrente L
J Am Chem Soc. 2024; 146(49):33324-33337.
PMID: 39586074
PMC: 11844218.
DOI: 10.1021/jacs.4c06296.
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.
Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S
Mol Cancer. 2024; 23(1):255.
PMID: 39543600
PMC: 11566504.
DOI: 10.1186/s12943-024-02130-8.